Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Retatrutide for Sale > Retatrutide 40mg Peptide Research Compound Lyophilized Powder Material
Retatrutide 40mg Peptide Research Compound Lyophilized Powder Material buy - large image1
Retatrutide 40mg Peptide Research Compound Lyophilized Powder Material buy - image1
Retatrutide 40mg Peptide Research Compound Lyophilized Powder Material buy - image2
Retatrutide 40mg Peptide Research Compound Lyophilized Powder Material buy - image3
Retatrutide 40mg Peptide Research Compound Lyophilized Powder Material buy - image4
Retatrutide 40mg Peptide Research Compound Lyophilized Powder Material buy - image5
Retatrutide 40mg Peptide Research Compound Lyophilized Powder Material buy - image6

Retatrutide 40mg Peptide Research Compound Lyophilized Powder Material

TDS 7270 Inquiries

Unit Price: Get Latest Price
CAS No.:

2381089-83-2

Grade:

Research Grade

Content:

99%

Port:

深圳

Brand:

Generic

Packaging:

40mg/Vial

Price valid (until):

2026-09-20

Company Type:
Trader
Location:
China
Payment Terms:
TT against copy of documents,100% TT in advance
Average Lead Time:
1 days
Qualification:
Main Products:

Peptides

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Name:Elare

    Whatsapp:+852 5535 7215

    Please add me for our latest price list and COA


      Product Detail  





    Retatrutide 40mg Peptide Research Compound Lyophilized Powder Material

    Product Overview

    Retatrutide 40mg Peptide Research Compound is a synthetic peptide research material supplied in a lyophilized powder format. This product is designed for laboratory research applications in peptide science, biochemical analysis, molecular studies, and related scientific fields.

    The product is provided in a standardized 40mg vial specification, offering researchers a convenient quantity for laboratory evaluation, analytical testing, and scientific investigation. The freeze-dried powder form supports convenient storage and handling under appropriate laboratory conditions.

    Retatrutide is a complex synthetic peptide compound studied as a research material due to its unique molecular structure and biochemical characteristics. This product is supplied as a research reagent and is intended exclusively for laboratory research purposes.


    Product Information

    Product Name:
    Retatrutide 40mg Peptide Research Compound Lyophilized Powder Material

    Product Category:
    Synthetic Peptide Research Compound

    Specification:
    40mg/vial

    Appearance:
    White to off-white lyophilized powder

    Physical Form:
    Freeze-dried solid powder

    Grade:
    Research Grade

    Usage Classification:
    Research Use Only (RUO)

    Packaging:
    Sealed vial packaging


    Chemical Information

    Compound Name: Retatrutide

    CAS Number: 2381089-83-2

    Molecular Weight: Approximately 4731.33 g/mol

    Chemical Type: Synthetic peptide compound

    Retatrutide is a peptide-based research compound produced through controlled synthesis and purification processes. Due to its complex molecular structure, proper laboratory storage and handling procedures are recommended to maintain product quality and consistency.


    Product Characteristics

    Synthetic Peptide Material

    Retatrutide 40mg is manufactured as a synthetic peptide research compound. The product is supplied in a standardized form to support laboratory studies requiring peptide reference materials.

    Lyophilized Powder Format

    The product is supplied as a freeze-dried powder, a commonly used format for peptide research materials.

    Advantages of lyophilized form include:

    • Convenient storage
    • Reduced moisture exposure
    • Easy transportation
    • Compatibility with laboratory preparation procedures

    Standardized Packaging

    The 40mg vial specification provides researchers with a practical packaging option for laboratory inventory management and research planning.


    Product Specifications

    Item Specification
    Product Name Retatrutide 40mg Peptide Research Compound
    Product Type Synthetic Peptide Material
    Appearance White to off-white powder
    Form Lyophilized powder
    Net Content 40mg/vial
    Application Laboratory Research
    Storage Controlled laboratory conditions
    Classification Research Use Only

    Research Applications

    Retatrutide 40mg may be used as a research material in various scientific areas.

    Peptide Chemistry Research

    The product can be utilized as a reference compound for peptide-related studies, including structural evaluation, analytical research, and laboratory methodology development.

    Biochemical Analysis

    Researchers may use this peptide material in laboratory studies involving biochemical characterization and compound analysis.

    Molecular Research

    The product may support scientific investigations related to molecular properties, peptide interactions, and analytical evaluation.

    Laboratory Method Development

    Retatrutide research material can be used in the development and assessment of laboratory analytical methods.


    Manufacturing Process

    Retatrutide 40mg is produced through controlled peptide synthesis and purification procedures.

    The manufacturing process focuses on:

    • Raw material evaluation
    • Controlled synthesis parameters
    • Purification process management
    • Product identification
    • Quality verification

    Advanced manufacturing procedures help maintain product consistency and support reliable research applications.


    Quality Control

    Quality Management

    Quality control procedures are implemented to ensure product consistency and reliability.

    Quality evaluation may include:

    • Appearance inspection
    • Identity confirmation
    • Purity analysis
    • Batch documentation review
    • Analytical testing

    Analytical Methods

    Common analytical techniques used for peptide research materials may include:

    • High Performance Liquid Chromatography (HPLC)
    • Mass Spectrometry (MS)
    • Laboratory characterization methods

    Quality documentation may be provided according to supplier specifications.


    Physical Appearance

    Retatrutide 40mg is supplied as a white to off-white lyophilized powder.

    Product appearance characteristics:

    • Solid powder form
    • Uniform packaging format
    • Clear product identification
    • Suitable for laboratory storage

    Minor appearance variations may occur depending on production conditions and handling procedures.


    Packaging Information

    Standard Packaging

    The product is supplied in sealed vial packaging.

    Package details:

    • Product specification: 40mg/vial
    • Container type: Laboratory vial
    • Product form: Lyophilized powder
    • Label information: Product identification and batch details

    The packaging system is designed to support product protection, identification, and laboratory management.


    Storage Recommendations

    Proper storage conditions are recommended to maintain product quality.

    Suggested storage practices:

    • Keep container tightly sealed
    • Store in a dry environment
    • Avoid excessive humidity
    • Protect from unsuitable environmental conditions
    • Follow laboratory storage procedures

    Researchers should manage storage conditions according to institutional requirements and product handling guidelines.


    Handling Information

    Retatrutide 40mg should be handled by trained laboratory personnel.

    Recommended handling practices:

    • Use appropriate laboratory equipment
    • Maintain clean working conditions
    • Follow laboratory safety procedures
    • Avoid improper storage or handling
    • Maintain accurate product records

    This product is supplied for research use only.


    Product Advantages

    Reliable Research Specification

    The 40mg vial format provides a standardized quantity suitable for laboratory planning and material management.

    Professional Peptide Format

    The lyophilized powder form provides convenience for research workflows and analytical applications.

    Consistent Product Quality

    Controlled production and quality procedures support reliable product characteristics.

    Wide Research Compatibility

    The product may support various peptide-related scientific studies and laboratory applications.

    Clear Product Identification

    Detailed product information helps researchers manage materials efficiently.


    Application Keywords

    Retatrutide 40mg

    Retatrutide Peptide

    Peptide Research Compound

    Synthetic Peptide Material

    Lyophilized Peptide Powder

    Research Grade Peptide

    Laboratory Research Reagent

    Biochemical Research Material

    Molecular Research Compound

    Scientific Research Chemical


    Frequently Asked Questions

    What is Retatrutide 40mg?

    Retatrutide 40mg is a synthetic peptide research compound supplied as a lyophilized powder for laboratory research applications.

    What is the specification?

    The standard specification is 40mg per vial.

    What is the product appearance?

    The product is supplied as a white to off-white lyophilized powder.

    What are the main applications?

    The product is used as a research material for peptide studies, biochemical analysis, molecular research, and laboratory evaluation.

    Is Retatrutide 40mg for human use?

    No. This product is supplied strictly for research use only and is not intended for human consumption, clinical use, or diagnostic applications.

    What type of packaging is available?

    The product is supplied in sealed laboratory vial packaging with a 40mg specification.


    Echemi Short Product Description

    Retatrutide 40mg Peptide Research Compound is a synthetic peptide material supplied as white to off-white lyophilized powder. With a standardized 40mg/vial specification, this research compound is suitable for laboratory studies, peptide analysis, biochemical research, and molecular investigations. Supplied for research use only with professional packaging and quality documentation.


    Echemi Product Highlights

    • Synthetic peptide research compound
    • 40mg standardized vial specification
    • White to off-white lyophilized powder
    • Suitable for laboratory research applications
    • Professional research material packaging
    • Controlled quality management process
    Items Specifications
    Product Name Retatrutide
    Grade Research Grade
    Package 40mg/Vial
    Appearance White Lyophilized Powder
    Model Retatrutide 40mg
    Brand Generic

    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 1

    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 2
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 3
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 4
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 5
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 6
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 7
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 8
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 9
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 10
    ECHEMI Editorial Reference
    Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.Retatrutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.Retatrutide is a synthetic peptide with glucose-lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating insulin and suppressing glucagon secretion in a glucose-dependent manner.Retatrutide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake and reduce body weight in patients with type 2 diabetes.
    Retatrutide (LY-3437943) was discovered by the American pharmaceutical company Eli Lilly and Company. It is a triple glucagon hormone receptor agonist (GLP-1, GIP, and GCGR receptors) for obesity. The 2024 Lasker~DeBakey Clinical Medical Research Award has been given to Joel Habener and Svetlana Mojsov for their discovery of a new hormone GLP-1(7-37) and to Lotte Knudsen for her role in developing sustained acting versions of this hormone as a treatment for obesity.

    Certificates
    • Retatrutide 40mg Peptide Research Compound Lyophilized Powder Material Certificates 1 TDS

    Basic Info
    Product Name:

    Retatrutide

    Other Name:

    Retatrutide;GIPR/GLP-1R;LY3437943Retatrutide;Retalutide;Retatrutide (sodium salt);Retatrutide RT5;retatrutide 5mg;Retatratide

    CAS No.:

    2381089-83-2

    InChIKeys:

    MLOLQJNKXBNWFW-SAGGEDDASA-N

    Molecular Weight:

    0

    EC Number:

    200-001-8

    Color/Form:

    White lyophilized

    Characteristics
    Water Solubility:

    Soluble in water (5mg/ml).

    Storage Conditions:

    -20°C

    Critical Temperature & Pressure:

    -20°C

    Research
    Class:

    Triple agonist — GCGR, GIPR, GLP-1R

    Status:

    Investigational (Phase 3)

    Mechanism:

    Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.

    EC50 (Human GCGR):

    5.79 nM

    EC50 (Mouse GIPR):

    0.191 nM

    EC50 (Mouse GLP1R):

    0.794 nM

    EC50 (Mouse GCGR):

    2.32 nM

    EC50 (Human GLP1R):

    0.775 nM

    EC50 (Human GIPR):

    0.0643 nM

    Source:

    Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI

    Clinical Development:

    NCT04881760; NCT05882045; NCT06354660

    References
    ChEMBL:

    CHEMBL5095485

    DrugBank:

    DB18993

    KEGG DRUG:

    D12430

    PubChem:

    PubChem

    Disclaimer:

    Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Peptides

    Location:

    Y17, Room 310, East Third Floor, No. 64 and 66 Jianzhong Road, Tianhe District, Guangzhou City

    Payment Terms:

    TT against copy of documents,100% TT in advance

    Average lead Time:

    1 days

    Total Employees:

    11-50

    Year of Establishment:

    2026

    Founded in 2024, PGpeptides is a specialized supplier of high-purity
    research peptides serving the global scientific community. With deep
    industry expertise, we deliver consistent product quality, competitive
    pricing, and flexible service tailored to research institutions, laboratories,
    and distributors worldwide.
    Our operations span North America, Europe, Asia, Australia, and the
    Middle East, backed by a mature international trade infrastructure and a
    reliable global fulfillment network. We have earned strong recognition 
    and trust across the markets we serve.
  • Inquiry History
    7270 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Retatrutide 2381089-83-2

    3 MT Mar 28, 2026
    United Kingdom

    Retatrutide - 2381089-83-2

    1 G Feb 10, 2026
    United States

    Retatrutide CAS 2381089-83-2 10mg vial

    20 MT Mar 7, 2026
    United States

    Factory Retatrutide API 99% Purity CAS 2381089-83-2

    5 KG Nov 10, 2025
    United Kingdom

    Peptide powder Retatrutide 99% pure for Body building cas 2381089-83-2 Weight Loss Peptide with COA

    1 MT Mar 22, 2026
    United States

    2381089-83-2

    100 MT Dec 9, 2023
    United States

    2381089-83-2

    100 G Jul 14, 2026
    United States

    2381089-83-2

    100 G Feb 24, 2026
    United States

    Retatrutide 2381089-83-2

    200 MG May 16, 2026
    United Kingdom

    2381089-83-2 retatrutide

    300 MG Feb 13, 2026
    United States

    Retatrutide 2381089-83-2 wholesale

    500 MT Nov 3, 2023
    United States

    Retatrutide CAS 2381089-83-2 99%

    10 PCS Feb 21, 2026
    Poland

    CAS 2381089-83-2 (Custom Peptide)

    40 MT Apr 10, 2026
    Austria

    Peptide Retatruide CAS 2381089-83-2

    100 MT Apr 4, 2026
    Austria

    Retatrutide CAS 2381089-83-2 10mg vial

    20 PCS Feb 10, 2026
    United States

    Retatrutide 99% High Quality CAS 2381089-83-2

    1 G Jan 23, 2026
    United States

    GLP-1 / GIP Retatrutide cas 2381089-83-2

    1 MT Oct 16, 2024
    United States

    Injection Peptide Tirzepatide/Retatrutide/ Semaglutide Peptides CAS 2381089-83-2

    10  Oct 21, 2023
    Australia

    GMP Grade 99% Retatrutide Lyophilized Powder CAS 2381089-83-2

    10 G Jun 12, 2026
    Hongkong, China

    Retatrutide CAS 2381089-83-2 safe delivery strong Lyophilized powder Vial

    20  Jan 25, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.